New Prevention Technologies
20 July 2010, AIDS 2010Ebony Johnsson
www.gnpplus.net
At LIVING 2008 Summit
Discussion paper on “Positive Prevention”:• Recognition of current research on NPTs (vaccines, microbicides, PrEP, Tx for Px)• Recommendation to explore role of PLHIV in NPT research and development
2
www.gnpplus.net
NPT Working Group - 1
3
• Convened September 2009• Objectives:
– Support the process of documenting the experiences and perspectives of PLHIV on NPTs;
– Highlight and advocate for opportunities for PLHIV to be involved in NPT R&D;
– Inform regional and national PLHIV networks of developments in the NPT field.
www.gnpplus.net
NPT Working Group – 26 Networks of PLHIV1. APN+2. All-Ukrainian
Network of PLHIV3. GNP+NA4. NEPHAK (Kenya)5. PozFem UK6. RedLa+
4 Partner Organizations1. EATG2. ICW Global3. ITPC/ HIV
Collaborative Fund4. TAC
4
www.gnpplus.net
Four Moderated and Structured Teleconferences
• Research site investigators• Site staff• People living with HIV
www.gnpplus.net
Online discussion forum
www.gnpplus.net
Key discussion points
• Meaningful roles for PLHIV in discussions on HIV prevention research ethics
• Meaningful roles for PLHIV in addressing questions on ARV-based prevention
• Collaboration between treatment and prevention advocates to address ARV-based prevention
• Defining the role(s) of PLHIV in HIV prevention trials
7
www.gnpplus.net
OutputsDiscussion paper: • Exploration of the roles of PLHIV in
Biomedical Prevention Research Toolkit for networks of PLHIV: • New Prevention Tools – What are they? • What is their relevance for PLHIV?Participation and advocacy:• WHO PrEP & ART for Prevention
Consultations (November 2009)• International Microbicides Conference (May
2010)8
www.gnpplus.net
Follow-up: Face-to-Face Consultation
Amsterdam, 5-6 July
Scientific Community
• IAVI• IPM
Advocacy Community
• AVAC• GCM• IRMA
9
NPT Working Group Members
www.gnpplus.net
Discussions• Updates on current HIV
prevention trials• Open and constructive dialogue
about implications of NPT R&D for PLHIV:- Vaccines- Microbicides (Vaginal and Rectal)- PrEP - ART for prevention
www.gnpplus.net
We are developing an advocacy agenda!
• Teleconferences, online discussions and face-to-face consultation will inform our advocacy agenda
• Development and revision process: July 2010 – December 2010
11
www.gnpplus.net
Initial recommendations• Clarify range of Tx and Px linkages and
implications for PLHIV• Develop guidance on ‘risk’ and ‘shared
responsibility’ for PLHIV• Clarify target audiences of NPTs and plans for
access at country-level• Map out what ‘meaningful engagement’ of
PLHIV in clinical trials would look like• Develop clear guidelines for networks of PLHIV
and normative agencies on representation in international consultations and meetings
12
www.gnpplus.net
Learn more!Poster presentation:22 July 2010 12.30 –
14.30Poster number:
THPE0261
13
www.gnpplus.net
Thank you to the NPT Working Group and partners for supporting this programme!
For more information, visit www.gnpplus.net
14
Top Related